Hypopyon after Periocular Corticosteroid Injection: A Case Series

References

• Sen HN, Vitale S, Gangaputra SS, et al. Periocular corticosteroid injections in uveitis: effects and complications. Ophthalmology. 2014;121(11):2275–2286. doi:10.1016/j.ophtha.2014.05.021.
   PubMed Web of Science ®Google Scholar
• Sugar A, Bokosky JE, Meyer RF. A randomized trial of topical corticosteroids in epithelial healing after keratoplasty. Cornea. 1985;3:268–271.
   Google Scholar
• Tomas-Barberan S, Fagerholm P. Influence of topical treatment on epithelial wound healing and pain in the early postoperative period following photorefractive keratectomy. Acta Ophthalmol Scand. 1999;77(2):135–138. doi:10.1034/j.1600-0420.1999.770203.x.
   PubMedGoogle Scholar
• Chew EY, Glassman AR, Beck RW, et al.; Diabetic Retinopathy Clinical Research Network. Ocular side effects associated with peribulbar injections of triamcinolone acetonide for diabetic macular edema. Retina. 2011;31(2):284–289. doi:10.1097/IAE.0b013e3181f049a8.
   PubMed Web of Science ®Google Scholar
• Yoshikawa K, Kotake S, Ichiishi A, Sasamoto Y, Kosaka S, Matsuda H. Posterior sub-Tenon injections of repository corticosteroids in uveitis patients with cystoid macular edema. Jpn J Ophthalmol. 1995;39:71–76.
   PubMed Web of Science ®Google Scholar
• Leder HA, Jabs DA, Galor A, Dunn JP, Thorne JE. Periocular triamcinolone acetonide injections for cystoid macular edema complicating noninfectious uveitis. Am J Ophthalmol. 2011;152(3):441–448. doi:10.1016/j.ajo.2011.02.009.
   PubMed Web of Science ®Google Scholar
• Ferrante P, Ramsey A, Bunce C, Lightman S. Clinical trial to compare efficacy and side-effects of injection of posterior sub-Tenon triamcinolone versus orbital floor methylprednisolone in the management of posterior uveitis. Clin Exp Ophthalmol. 2004;32(6):563–568. doi:10.1111/j.1442-9071.2004.00902.x.
   PubMed Web of Science ®Google Scholar
• Kusaka S, Ikuno Y, Ohguro N, Hori Y, Tano Y. Orbital infection following posterior subtenon triamcinolone injection. Acta Ophthalmol Scand. 2007;85(6):692–693. doi:10.1111/j.1600-0420.2007.00959.x.
   PubMedGoogle Scholar
• Xu LJ, Song XS, Zhao J, Sun SY, Xie LX. Hypopyon in patients with fungal keratitis. Chin Med J (Engl). 2012;125:470–475.
   PubMed Web of Science ®Google Scholar
• Jackson TL, Paraskevopoulos T, Georgalas I. Systematic review of 342 cases of endogenous bacterial endophthalmitis. Surv Ophthalmol. 2014;59(6):627–635. doi:10.1016/j.survophthal.2014.06.002.
   PubMed Web of Science ®Google Scholar
• Zaidi AA, Ying GS, Daniel E, et al. Systemic immunosuppressive therapy for eye diseases cohort study. Hypopyon in patients with uveitis. Ophthalmology. 2010;117(2):366–372. doi:10.1016/j.ophtha.2009.07.025.
   PubMed Web of Science ®Google Scholar
• Winegarner A, Hashida N, Koh S, Nishida K. Hemorrhagic hypopyon as presenting feature of intravascular lymphoma, a case report. BMC Ophthalmol. 2017;17(1):195. doi:10.1186/s12886-017-0591-3.
   PubMedGoogle Scholar
• Bhagat N, Read RW, Rao NA, Smith RE, Chong LP. Rifabutin-associated hypopyon uveitis in human immunodeficiency virus-negative immunocompetent individuals. Ophthalmology. 2001;108(4):750–752. doi:10.1016/S0161-6420(00)00586-8.
   PubMed Web of Science ®Google Scholar
• Hernandez-Bogantes E, Navas A, Naranjo A, et al. Toxic anterior segment syndrome: a review. Surv Ophthalmol. 2019;64(4):463–476. doi:10.1016/j.survophthal.2019.01.009.
   PubMed Web of Science ®Google Scholar
• Austin A, Lietman T, Rose-Nussbaumer J. Update on the management of infectious keratitis. Ophthalmology. 2017;124(11):1678–1689. doi:10.1016/j.ophtha.2017.05.012.
   PubMed Web of Science ®Google Scholar
• Cho CH, Lee SB. Clinical analysis of microbiologically proven fungal keratitis according to prior topical steroid use: a retrospective study in South Korea. BMC Ophthalmol. 2019;19(1):207. doi:10.1186/s12886-019-1212-0.
   PubMed Web of Science ®Google Scholar
• McClellan K, Howard K, Niederkorn JY, Alizadeh H. Effect of steroids on acanthamoeba cysts and trophozoites. Invest Ophthalmol Vis Sci. 2001;42:2885–2893.
   PubMed Web of Science ®Google Scholar
• Holland EJ, Schwartz GS. Classification of herpes simplex virus keratitis. Cornea. 1999;18(2):144–154. doi:10.1097/00003226-199903000-00002.
   PubMed Web of Science ®Google Scholar
• Tsatsos M, MacGregor C, Athanasiadis I, Moschos MM, Hossain P, Anderson D. Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents. Clin Exp Ophthalmol. 2016;44(9):824–837. doi:10.1111/ceo.12785.
   PubMed Web of Science ®Google Scholar
• Knickelbein JE, Hendricks RL, Charukamnoetkanok P. Management of herpes simplex virus stromal keratitis: an evidence-based review. Surv Ophthalmol. 2009;54(2):226–234. doi:10.1016/j.survophthal.2008.12.004.
   PubMed Web of Science ®Google Scholar
• Lobo AM, Agelidis AM, Shukla D. Pathogenesis of herpes simplex keratitis: the host cell response and ocular surface sequelae to infection and inflammation. Ocul Surf. 2019;17(1):40–49. doi:10.1016/j.jtos.2018.10.002.
   PubMed Web of Science ®Google Scholar
• Wilhelmus KR, Gee L, Hauck WW, et al. Herpetic eye disease study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology. 1994;101(12):1883–1895. doi:10.1016/S0161-6420(94)31087-6.
   PubMed Web of Science ®Google Scholar
• Weijtens O, Feron EJ, Schoemaker RC, et al. High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection. Am J Ophthalmol. 1999;128(2):192–197. doi:10.1016/S0002-9394(99)00129-4.
   PubMed Web of Science ®Google Scholar
• Weijtens O, Schoemaker RC, Romijn FP, Cohen AF, Lentjes EG, van Meurs JC. Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate. Ophthalmology. 2002;109(10):1887–1891. doi:10.1016/S0161-6420(02)01176-4.
   PubMed Web of Science ®Google Scholar
• Inoue Y. Review of clinical and basic approaches to corneal endotheliitis. Cornea. 2014;33(11):S3–8. doi:10.1097/ICO.0000000000000228.
   PubMedGoogle Scholar
• Fukuda M, Deai T, Higaki S, Hayashi K, Shimomura Y. Presence of a large amount of herpes simplex virus genome in tear fluid of herpetic stromal keratitis and persistent epithelial defect patients. Semin Ophthalmol. 2008;23(4):217–220. doi:10.1080/08820530802111366.
   PubMedGoogle Scholar
• Wensing B, Mochizuki M, De Boer JH. Clinical characteristics of herpes simplex virus associated anterior uveitis. Ocul Immunol Inflamm. 2018;26(3):333–337. doi:10.1080/09273948.2017.1420806.
   PubMed Web of Science ®Google Scholar
• Yu T, Peng RM, Xiao GG, Feng LN, Hong J. Clinical evaluation of intravitreal injection of ganciclovir in refractory corneal endotheliitis. Ocul Immunol Inflamm. 2020;28(2):270–280. doi:10.1080/09273948.2019.1573261.
   PubMed Web of Science ®Google Scholar
• Choi WS, Cho JH, Kim HK, Kim HS, Shin YJ. A case of CMV endotheliitis treated with intravitreal ganciclovir injection. Korean J Ophthalmol. 2013;27(2):130–132. doi:10.3341/kjo.2013.27.2.130.
   PubMedGoogle Scholar
• Ghate D, Edelhauser HF. Ocular drug delivery. Expert Opin Drug Deliv. 2006;3(2):275–287. doi:10.1517/17425247.3.2.275.
   PubMedGoogle Scholar
• Pue MA, Pratt SK, Fairless AJ, et al. Linear pharmacokinetics of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 mg to healthy volunteers. J Antimicrob Chemother. Jan 1994;33(1):119–127. doi:10.1093/jac/33.1.119.
   PubMed Web of Science ®Google Scholar
• Diaz-Mitoma F, Sibbald RG, Shafran SD, Boon R, Saltzman RL. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group. JAMA. 1998 Sep 9;280(10):887–892. doi:10.1001/jama.280.10.887.
   PubMed Web of Science ®Google Scholar
• Koseoglu ND, Strauss BR, Hamrah P. Successful management of herpes simplex keratitis with oral valganciclovir in patients unresponsive or allergic to conventional antiviral therapy. Cornea. Jun 2019;38(6):663–667. doi:10.1097/ICO.0000000000001917.
   PubMed Web of Science ®Google Scholar
• Morfin F, Thouvenot D. Herpes simplex virus resistance to antiviral drugs. J Clin Virol. 2003;26(1):29–37. doi:10.1016/s1386-6532(02)00263-9.
   PubMed Web of Science ®Google Scholar
• Kozak I, Allen Mccutchan J, and William RF. HIV-associated infections. In: Schachat AP, ed. Ryan’s Retina. 6th ed. Edinburgh: Elsevier; 2018:1631.
   Google Scholar
• Boisjoly HM, Pavan-Langston D, Kenyon KR, et al. Superinfections in herpes simplex keratitis. Am J Ophthalmol. 1983;96:354–361. doi:10.1016/S0002-9394(14)77827-4.
   PubMed Web of Science ®Google Scholar
• Schaefer F, Brutin O, Zografos L, et al. Bacterial keratitis: a prospective clinical and microbiological study. British J Ophthalmol. 2001;85:842–847. doi:10.1136/bjo.85.7.842.
   PubMed Web of Science ®Google Scholar